Vivos Therapeutics (VVOS) Short Interest Ratio & Short Volume → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free VVOS Stock Alerts $2.09 +0.14 (+7.18%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Vivos Therapeutics Short Interest DataCurrent Short Interest46,400 sharesPrevious Short Interest62,800 sharesChange Vs. Previous Month-26.11%Dollar Volume Sold Short$101,152.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares3,230,000 sharesFloat Size2,990,000 sharesShort Percent of Float1.55%Today's Trading Volume18,668 sharesAverage Trading Volume70,336 sharesToday's Volume Vs. Average27% Short Selling Vivos Therapeutics ? Sign up to receive the latest short interest report for Vivos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVVOS Short Interest Over TimeVVOS Days to Cover Over TimeVVOS Percentage of Float Shorted Over Time Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. Vivos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202446,400 shares $101,152.00 -26.1%1.6%0.3 $2.18 4/30/202462,800 shares $158,884.00 -67.1%2.3%0.3 $2.53 4/15/2024191,100 shares $529,347.00 +921.9%7.6%0.9 $2.77 3/31/202418,700 shares $90,321.00 -28.6%0.8%0.1 $4.83 3/15/202426,200 shares $117,900.00 +11.0%2.3%0.2 $4.50 2/29/202423,600 shares $137,116.00 -19.2%2.1%0.1 $5.81 Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202429,200 shares $156,512.00 -38.1%2.6%0 $5.36 1/31/202447,200 shares $347,864.00 +237.1%4.2%0 $7.37 1/15/202414,000 shares $111,300.00 -84.0%1.2%0 $7.95 12/31/202387,300 shares $1.09 million -46.2%N/A0 $12.44 12/15/2023162,300 shares $1.49 million +512.5%14.6%0.1 $9.21 11/30/202326,500 shares $649,250.00 -31.2%2.4%0 $24.50 11/15/202338,500 shares $148,225.00 +13.2%3.9%0.2 $3.85 10/31/202334,000 shares $109,140.00 -98.5%3.4%0.2 $3.21 10/15/20232,270,000 shares $732,302.00 +297.1%N/A0.4 $0.32 9/30/2023571,600 shares $109,804.36 +8.3%N/A0.1 $0.19 9/15/2023527,700 shares $129,286.50 -18.9%N/A0.3 $0.25 8/31/2023650,300 shares $163,420.39 -43.0%N/A0.4 $0.25 8/15/20231,140,000 shares $372,096.00 +1,388.3%N/A0.7 $0.33 7/31/202376,600 shares $22,290.60 -33.6%N/A0.1 $0.29 7/15/2023115,300 shares $36,492.45 +63.3%N/A0.5 $0.32 6/30/202370,600 shares $36,006.00 -69.7%N/A0.5 $0.51 6/15/2023232,900 shares $128,421.06 -5.2%N/A1.4 $0.55 5/31/2023245,600 shares $93,720.96 +11.5%N/A1.3 $0.38 5/15/2023220,200 shares $72,666.00 +48.1%N/A0.3 $0.33 4/30/2023148,700 shares $51,152.80 -21.9%N/A0.2 $0.34 4/15/2023190,400 shares $63,574.56 +31.7%N/A0.3 $0.33 3/31/2023144,600 shares $49,323.06 -45.1%N/A0.2 $0.34 3/15/2023263,500 shares $96,599.10 +449.0%1.3%0.1 $0.37 2/28/202348,000 shares $29,280.00 -82.9%0.2%0 $0.61 2/15/2023281,000 shares $256,384.40 -5.9%1.4%0.1 $0.91 1/31/2023298,700 shares $325,583.00 -65.5%1.7%0.1 $1.09 1/15/2023865,100 shares $1.51 million +576.4%4.8%0.4 $1.75 12/30/2022127,900 shares $51,415.80 +10.6%0.7%0.1 $0.40 12/15/2022115,600 shares $40,286.60 -16.4%0.6%1.6 $0.35 11/30/2022138,200 shares $69,100.00 -17.8%0.8%3.5 $0.50 11/15/2022168,200 shares $115,368.38 -22.8%0.9%4.9 $0.69 10/31/2022217,900 shares $156,888.00 +29.0%1.2%5.2 $0.72 10/15/2022168,900 shares $116,000.52 -0.2%0.9%4 $0.69 9/30/2022169,300 shares $110,028.07 +19.1%0.9%4.2 $0.65What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. 9/15/2022142,100 shares $161,994.00 -20.9%0.8%3.8 $1.14 8/31/2022179,600 shares $220,908.00 +26.5%1.0%4.3 $1.23 8/15/2022142,000 shares $200,220.00 -43.6%0.8%3 $1.41 7/31/2022251,600 shares $289,340.00 +19.9%1.4%5.3 $1.15 7/15/2022209,800 shares $295,818.00 -17.4%1.2%3.9 $1.41 6/30/2022254,100 shares $327,789.00 -3.6%1.5%4.3 $1.29 6/15/2022263,500 shares $337,280.00 -32.5%1.5%3.5 $1.28 5/31/2022390,500 shares $792,715.00 -4.9%2.3%4.9 $2.03 5/15/2022410,700 shares $570,873.00 +50.6%2.4%3.5 $1.39 4/30/2022272,800 shares $471,944.00 -32.2%1.6%1.9 $1.73 4/15/2022402,300 shares $788,508.00 -16.8%2.3%0.8 $1.96 3/31/2022483,600 shares $1.30 million -5.7%2.8%0.2 $2.68 3/15/2022512,900 shares $1.38 million -31.4%3.0%0.2 $2.69 2/28/2022747,700 shares $2.50 million +54.3%4.3%0.4 $3.34 2/15/2022484,700 shares $1.17 million -60.6%2.8%0.2 $2.42 1/31/20221,230,000 shares $3.04 million +760.1%7.1%0.6 $2.47 1/15/2022143,000 shares $267,410.00 -10.8%1.0%0.1 $1.87 12/31/2021160,300 shares $360,675.00 -15.8%1.2%1.2 $2.25 12/15/2021190,400 shares $531,216.00 -36.6%1.4%1.3 $2.79 11/30/2021300,300 shares $765,765.00 -19.0%2.2%1.4 $2.55 11/15/2021370,800 shares $1.51 million -11.6%2.7%1.1 $4.06 10/29/2021419,400 shares $1.52 million +41.6%3.1%0.1 $3.63 10/15/2021296,200 shares $1.05 million +3.6%2.2%0.1 $3.55 9/30/2021285,800 shares $1.15 million -0.1%2.1%0.1 $4.04 9/15/2021286,200 shares $1.35 million -56.2%2.1%0.1 $4.73 8/31/2021652,700 shares $3.43 million +1,390.2%4.8%0.2 $5.26 8/13/202143,800 shares $143,226.00 -25.8%0.3%0 $3.27 7/30/202159,000 shares $178,180.00 -50.7%0.4%0.2 $3.02 7/15/2021119,700 shares $514,710.00 +193.4%0.9%0.4 $4.30 6/30/202140,800 shares $201,960.00 -17.7%0.3%0.1 $4.95 6/15/202149,600 shares $288,176.00 -22.0%0.4%0.3 $5.81 5/28/202163,600 shares $342,168.00 +1.0%0.5%0.3 $5.38 5/14/202163,000 shares $372,960.00 +90.3%0.5%0.4 $5.92 4/30/202133,100 shares $223,425.00 -45.7%0.3%0.2 $6.75 4/15/202160,900 shares $542,010.00 +45.4%0.6%0.3 $8.90 3/31/202141,900 shares $283,663.00 +165.2%0.4%0.2 $6.77 3/15/202115,800 shares $117,552.00 -31.9%0.2%0.1 $7.44 2/26/202123,200 shares $174,928.00 -33.9%0.2%0 $7.54 2/12/202135,100 shares $245,349.00 +317.9%0.3%0.1 $6.99 1/29/20218,400 shares $56,658.00 -88.0%0.1%0 $6.75 1/15/202170,100 shares $560,099.00 No Change0.6%0.1 $7.99 VVOS Short Interest - Frequently Asked Questions What is Vivos Therapeutics' current short interest? Short interest is the volume of Vivos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 46,400 shares of VVOS short. 1.55% of Vivos Therapeutics' shares are currently sold short. Learn More on Vivos Therapeutics' current short interest. What is a good short interest percentage for Vivos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.55% of Vivos Therapeutics' floating shares are currently sold short. Is Vivos Therapeutics' short interest increasing or decreasing? Vivos Therapeutics saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 46,400 shares, a decrease of 26.1% from the previous total of 62,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vivos Therapeutics' float size? Vivos Therapeutics currently has issued a total of 3,230,000 shares. Some of Vivos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vivos Therapeutics currently has a public float of 2,990,000 shares. How does Vivos Therapeutics' short interest compare to its competitors? 1.55% of Vivos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Vivos Therapeutics: Inspira Technologies Oxy B.H.N. Ltd. (0.86%), Nephros, Inc. (0.03%), Lyra Therapeutics, Inc. (0.99%), Meihua International Medical Technologies Co., Ltd. (0.12%), PAVmed Inc. (5.35%), Microbot Medical Inc. (2.12%), STRATA Skin Sciences, Inc. (0.42%), NEXGEL, Inc. (0.44%), Plus Therapeutics, Inc. (2.89%), GlucoTrack, Inc. (0.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Vivos Therapeutics stock? Short selling VVOS is an investing strategy that aims to generate trading profit from Vivos Therapeutics as its price is falling. VVOS shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vivos Therapeutics? A short squeeze for Vivos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VVOS, which in turn drives the price of the stock up even further. How often is Vivos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVOS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: IINN Short Interest NEPH Short Interest LYRA Short Interest MHUA Short Interest PAVM Short Interest MBOT Short Interest SSKN Short Interest NXGL Short Interest PSTV Short Interest GCTK Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VVOS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBiden replacement revealed?Paradigm PressThis unknown company solves the biggest issue with AIManward PressTrump conviction scandal exposedPorter & CompanyNvidia has Apple and Microsoft within striking rangeWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.